Citations

Clear

116 citation(s) found for "Davis, Mark".

Baseline characteristics and long‐term outcomes of eosinophilic fasciitis in 89 patients seen at a single center over 20 years
Mango, Robert L., Bugdayli, Kubra, Crowson, Cynthia S. , Drage, Lisa A., Wetter, David A. , Lehman, Julia S. , Peters, Margot S. , Davis, Mark D. P. , Chowdhary, Vaidehi , Davis, Mark D., Chowdhary, Vaidehi R , Lehman, Julia S , Davis, Mark D.P.

Mayo Clinic

International Journal of Rheumatic Diseases | December 7, 2019 | Volume: 23 | Issue: 2 | Pages: 233-239

10.1111/1756-185x.13770 | PMID 31811710 Get It

AbstractAimEosinophilic fasciitis (EF) is a rare, fibrosing disorder of skin and subcutaneous tissue. This study was undertaken to describe its clinical and laboratory features and identify prognostic factors associated with outcome.MethodsWe conducted a retrospective review of all EF patients evaluated at our institution from 1 January1997 to 30 December 2016. Kaplan‐Meier methods were used to determine treatment response rates over time. Potential associations between baseline characteristics and complete response were examined using Cox models adjusted for age and sex. Time‐dependent covariates were used to examine treatment effects.ResultsWe identified 89 EF patients, with a female‐to‐male ratio of 1:1. Clinical features included groove sign in 26 (29%), peau d'orange/dimpling in 22 (25%), inflammatory arthritis in 9 (10%) and muscle weakness in 9 (10%). Aldolase was elevated in 11/36 (31%). Complete response rate was 60% (95% confidence interval [CI]: 35‐75) at 3 years. Diagnostic delay was inversely associated with treatment response (hazards ratio: 0.84 per 1 month increase; 95% CI: 0.73‐0.98). No baseline characteristics correlated with treatment response, but a trend toward positive association of elevated aldolase, hypergammaglobulinemia and presence of hematologic disorders was noted. Methotrexate was the most commonly used immunosuppressant in 79%, hydroxychloroquine in 45%, mycophenolate mofetil in 18% and azathioprine in 8%. No single immunosuppressant agent was associated with a superior response during treatment.ConclusionsEF is characterized by relatively high response rates. Consensus diagnostic criteria, standardized management algorithms, and large prospective multi‐center cohorts are needed to develop an evidence‐directed approach to this challenging condition.
Patch Testing with a Large Series of Metal Allergens: Findings from More Than 1,000 Patients in One Decade at Mayo Clinic
Davis, Mark D.P. , Wang, Michael Z. , Yiannias, James A. , Keeling, James H., Connolly, Suzanne M., Richardson, Donna M., Farmer, Sara A.

Mayo Clinic

Dermatitis® | September 6, 2019 | Volume: 22 | Issue: 5 | Pages: 256-271

10.2310/6620.2011.11035 | PMID 22652903 Get It

Background: The standard allergen series used in patch testing contains metals that most commonly cause allergic contact dermatitis, but testing with additional metal allergens is warranted for select patients. Objective: To report our experience with patch testing of metals. Methods: We retrospectively analyzed outcomes of 1,112 patients suspected of having metal allergies. Patients were seen from January 1, 2000, through December 31, 2009. Patch testing was performed with 42 metal preparations (6 in the standard series, 36 in the metal series). Results: Patch testing most commonly was performed for patients with oral disease (almost half the patients), hand dermatitis, generalized dermatitis, and dermatitis affecting the lips, legs, arms, trunk, or face. At least one positive reaction was reported for 633 patients (57%). Metals with the highest allergic patch-test reaction rates were nickel, gold, manganese, palladium, cobalt, Ticonium, mercury, beryllium, chromium, and silver. Metals causing no allergic patch-test reactions were titanium, Vitallium, and aluminum powder. Metals with extremely low rates of allergic patch-test reactions included zinc, ferric chloride, and tin. Reaction rates varied depending on metal salt, concentration, and timing of readings. Conclusion: Many metals not in the standard series were associated with allergic patch-test reactions. The many questions raised by these findings, concerning patch testing with individual metals, will be the subject of future studies.
Patch-Testing with Hairdressing Chemicals
Wang, Michael Z. , Farmer, Sara A., Richardson, Donna M., Davis, Mark D.P.

Mayo Clinic

Dermatitis® | September 6, 2019 | Volume: 22 | Issue: 1 | Pages: 16-26

10.2310/6620.2010.10061 Get It

Background: Hairdressing chemicals may be associated with allergic contact dermatitis. Objective: To review our experience of patch-testing with hairdressing chemicals. Methods: We reviewed results from patients who underwent patch testing with our standard allergen series (including 15 hairdressing chemicals) and a supplementary “hairdresser series” (18 additional hairdressing chemicals) at Mayo Clinic (Rochester, MN; Scottsdale, AZ; and Jacksonville, FL) from January 1, 2000, through December 31, 2008. Results: Two hundred ten patients (mean age, 53.8 years [SD, 16.9 yr]; female, 94.8%) were patch-tested. The most common sites of dermatitis were the scalp, face, and hands. Patients had widely varying occupations. The most common occupations were cosmetologist (10.5%), housewife (9.5%), and beautician (5.2%); 14.3% were retired. The hairdresser series detected 13 additional patients with allergies (6.4%; 204 patients tested with both series) who would not have been detected with the standard allergen series alone. The highest allergic patch-test rates in the supplemental hairdresser series were with ammonium persulfate (14.4%), 4-aminoazobenzene (13.4%), and pyrogallol (9.1%). Conclusions: Patch-testing with hairdressing-specific chemicals (standard series plus supplemental hairdresser series) was appropriate for numerous clinical situations and was not limited to patients in hair care occupations. The supplemental hairdresser series helped identify more patients than would have been identified with the standard series alone.
Patch-Testing with Plastics and Glues Series Allergens
Shmidt, Eugenia , Farmer, Sara A., Davis, Mark D.P.

Mayo Clinic

Dermatitis® | September 6, 2019 | Volume: 21 | Issue: 5 | Pages: 269-274

10.2310/6620.2010.10024 Get It

Background: Few US studies have reported results of patch testing with plastics and glues. Objective: To report our institution's results of testing patients suspected of allergy to plastics and glues with a comprehensive plastics and glues series and to compare these results with previously published data. Methods: Retrospective review of results of patch-testing with plastics and glues allergens at our institution between 2000 and 2007. In total, 444 patients were patch-tested with up to 56 plastics and glues allergens in the specialized series and up to five plastics and glues allergens in a baseline series. Positive-reaction rates were compared to other patch testing reports. Results: Of patients, 97 (22%) had irritant reactions, and 201 (45%) had at least one allergic reaction. Bis(2-dimethylaminoethyl) ether 1%, benzoyl peroxide 1%, epoxy resin, bisphenol F 0.25%, 2-hydroxyethyl methacrylate 2%, and 2-hydroxyethyl acrylate 0.1% had the highest allergy reaction rates. Testing with specialized series identified 193 patients with plastics and glues allergy, of whom 162 were not identified by testing with baseline series alone. Conclusion: For patients suspected of allergy to plastics and glues, patch-testing with specialized series of plastics and glues allergens is an important adjunct to patch-testing with baseline series.
Photopatch Testing of 182 Patients: A 6-Year Experience at the Mayo Clinic
Scalf, Leigh Ann, Davis, Mark D.P. , Rohlinger, Audrey L., Connolly, Suzanne M.

Mayo Clinic

Dermatitis® | September 6, 2019 | Volume: 20 | Issue: 1 | Pages: 44-52

10.2310/6620.2008.08049 Get It

Background: Photopatch testing is important for diagnosing photoallergic contact dermatitis. Although results of photopatch testing have been presented from many European centers, there have been few reports of the results of photopatch testing in the United States. Objective: To review the Mayo Clinic’s recent experience with photopatch testing, identify common photoallergens, and compare our current and previous findings. Methods: We retrospectively reviewed records of patients who underwent photopatch testing at the Mayo Clinic between January 1, 2000, and December 31, 2005 (N=182). Results: Fifty-four patients (29.7%) had photoallergic contact reactions, and 29 (15.9%) had allergic contact reactions. The most common photoallergens were medications, sunscreen agents, fragrances, and antiseptics. Conclusion: Photopatch testing is the technique useful in identifying photoallergens. The series of allergens used must be constantly updated to reflect newly identified and outdated photoallergens. We present a 6-year experience with photopatch testing. Medications, sunscreen agents, fragrances, and antiseptics were the most frequently identified photoallergens.
An 8-Year Retrospective Review of Patch Testing with Rubber Allergens: The Mayo Clinic Experience
Bendewald, Margo J., Farmer, Sara A., Davis, Mark D. P. , Davis, Mark D.P.

Mayo Clinic

Dermatitis® | September 6, 2019 | Volume: 21 | Issue: 1 | Pages: 33-40

10.2310/6620.2009.09029 Get It

Background: Allergic contact dermatitis from rubber chemicals is increasingly recognized. Objective: To review the results of patch testing with rubber allergens from January 1, 2000, through December 31, 2007. Methods: Patients who underwent patch testing with a specialized series of rubber allergens were identified. Results: In total, 773 patients (64.2% female; mean age, 48.6 years) were patch-tested with a rubber series (27 allergens), and 739 (95.6%) were concomitantly patch-tested with a standard allergen series. Commonly affected sites of dermatitis were the hand (49.7%), foot (15.9%), leg (12.0%), and arm (10.9%). The most common occupations were health care worker (16.3%) and homemaker (6.5%); 11.3% were retired. The rate of allergic reaction to at least one rubber allergen was 245 of 773 (31.7%). The allergens that most commonly yielded positive reactions were 4,4-dithiodimorpholine 1% (28/286 [9.8%]), thiuram mix (56/739 [7.6%]), and diphenylguanidine 1% (57/759 [7.5%]). Conclusion: Rubber is a frequent cause of allergic contact dermatitis. Patch testing with a rubber series improved the ability to diagnose allergic contact dermatitis caused by rubber.
Patch Testing with Natural Rubber Latex: The Mayo Clinic Experience
Bendewald, Margo J., Farmer, Sara A., Davis, Mark D. P. , Davis, Mark D.P.

Mayo Clinic

Dermatitis® | September 6, 2019 | Volume: 21 | Issue: 6 | Pages: 311-316

10.2310/6620.2010.09066 Get It

Background: Delayed hypersensitivity reactions to natural rubber latex (NRL) have been recognized. These reactions may contribute to allergic contact dermatitis. We therefore have undertaken patch testing of patients with NRL if they are suspected to have allergic contact dermatitis to rubber. Objective: To review results of patch testing with NRL (January 1, 2000, through December 31, 2007). Methods: Patients suspected of having allergic contact dermatitis from rubber who underwent patch testing with NRL were identified retrospectively. For safety reasons, patients with immediate hypersensitivity to NRL were excluded from patch testing. Results: Of 148 patients patch-tested with NRL, 3 (2.0%) had an allergic patch-test reaction. Conclusions: NRL is as common a cause of allergic contact dermatitis as many of the other allergens included in a specialized rubber allergen series. Patients suspected to be allergic to rubber should be patch-tested with NRL (provided they do not have type 1 hypersensitivity to NRL).
Primary Cutaneous Acral CD8+ T-Cell Lymphoma—A Single Center Review of 3 Cases and Recent Literature Review
Tjahjono, Leonardo , Davis, Mark D.P. , Comfere, Nneka I. , Tjahjono, Leonardo A, Tjahjono, L A , Witzig, Thomas E.

Mayo Clinic

The American Journal of Dermatopathology | March 5, 2019 | Volume: 41 | Issue: 9 | Pages: 644-648

10.1097/dad.0000000000001366 | PMID 31433793 Get It

Abstract: The recently published 2016 revision of the WHO classification of lymphoid neoplasms includes primary cutaneous acral CD8-positive T-cell lymphoma (PCATCL) as a provisional entity. This is a rare indolent lymphoma characterized by papules or nodules on the ear and a dermal infiltrate of CD8-positive T-lymphocytes with cytotoxic marker expression. A retrospective review of a single institutional experience with PCATCL identified 3 patients (mean age 54; range 49–62) with papules or nodules on the ear. Lesional biopsies demonstrated a dense diffuse dermal infiltrate of atypical lymphocytes with a Grenz zone in 2 cases and focal epidermotropism in 1 case. The atypical lymphocytes were predominantly CD3 and CD8 positive with expression of cytotoxic marker TIA1. Staging evaluation failed to reveal systemic disease. Two patients underwent local excision, and the third received local radiation therapy all with complete response and no disease recurrence at last follow-up 3 months (range 2–5 months). Our cases add to the existing limited literature on the clinical and histopathological features of PCATCL. We also performed an updated systematic literature view of the entity.
Squamous Cell Carcinoma in Perineal, Perianal, and Gluteal Hidradenitis Suppurativa: Experience in 12 Patients
Kohorst, John J. , Shah, Kabeer , Hallemeier, Christopher L. , Baum, Christian L. , Davis, Mark D. P. , Hallemeier, Christopher Leigh , Davis, Mark D.P.

Mayo Clinic

Dermatologic Surgery | January 8, 2019 | Volume: 45 | Issue: 4 | Pages: 519-526

10.1097/dss.0000000000001713 | PMID 30608295 Get It

BACKGROUND Few reports describe squamous cell carcinoma (SCC) arising in hidradenitis suppurativa (HS). OBJECTIVE The 2 objectives were (1) to describe the clinical characteristics, pathologic findings, and postoperative outcomes of SCC in HS and (2) to assess whether human papillomavirus (HPV) is involved in the pathogenesis. MATERIALS AND METHODS Cases of SCC in HS were identified through institutional medical records (1976–2013) and the Rochester Epidemiology Project. Tumor specimens were assessed for HPV DNA/RNA with in situ hybridization. RESULTS Twelve patients were identified (11 Caucasians and 9 men). All SCCs involved gluteal, perianal, or perineal skin; 1 patient had, in addition, involvement of the vagina. Surgical excision was performed on all 12 patients, 4 of whom had a colostomy. Mean duration of HS before SCC development was 28.5 years (range, 15–53 years). Mean follow-up was 4.3 years after surgical excision. Seven of 12 patients followed had postoperative SCC recurrence. Squamous cell carcinoma caused death despite wide surgical excision in these 7 patients. Of the remaining 5 patients, 4 are unknown and 1 who did not recur had an in situ SCC (Bowen disease carcinoma). Squamous cell carcinoma was not associated with high-risk or low-risk HPV. CONCLUSION Invasive SCC arising in HS carries a high risk of death.